Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
April 18, 2024
OncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL Program
April 27, 2023
